Table 3. 30-day in-hospital adverse events.

Variable	Overall (N=107)	TEVAR (n=44)	Hybrid arch (n=27)	Hybrid TAAA (n=4)	Open descending (n=9)	Open TAAA (n=23)	P value
Stroke (neurologic deficit lasting >72 hours)	5 (5%)	0	0	0	1 (11%)	4 (17%)	0.01
Permanent paraplegia/paraparesis	3 (3%)	0	0	0	0	3 (13%)	0.06
Acute renal failure (Cr >2.0 mg/dL and >2× baseline)	6 (6%)	1 (2%)	2 (7%)	0	0	3 (13%)	0.40
New onset dialysis	1 (1%)	0	1 (4%)	0	0	0	0.59
Prolonged ventilation (>24 hours)	7 (7%)	1 (2%)	1 (4%)	0	0	5 (22%)	0.06
Myocardial infarction	1 (1%)	1 (2%)	0	0	0	0	0.99
Retrograde type A aortic dissection	3 (3%)	2 (5%)	1 (4%)	0	0	0	0.81
Death	5 (5%)	0	3 (11%)	0	1 (11%)	1 (4%)	0.11
Postoperative length of stay [days]	5 [3,8]	3 [2,5]	5 [3,6]	6 [6,8]	6 [5,6]	8 [7,12]	0.01

Data represented as median (interquartile range) or number (percent). Cr, creatinine; TAAA, thoracoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic repair.